Skip to Main Content

Paper Details

External Validation of the Rotterdam Prostate Cancer Risk Calculator and Comparison with Stockholm3 for Prostate Cancer Diagnosis in a Swedish Population-based Screening Cohort.
Eur Urol Focus
4
2023
PSA, Prostate Cancer, RPCRC, Stockholm3, csPC, men, participant, participants, prostate cancer, prostate-specific antigen
Author NameAffiliation
Henrik Gr??nbergKarolinska Institutet
Henrik Gr??nbergKarolinska Institutet
  • 1 - 2

Datasets

Release 1.2